A multicenter randomized study of adjuvant heat-shock protein peptide-complex 96 (HSPPC-96) vaccine in patients with high-risk of recurrence after nephrectomy for renal cell carcinoma (RCC)-a preliminary report.

Christopher G. Wood,Bernard Escudier,S. Gorelov,K. Krajka,Louis Lacombe,S. D. Fosså,Axel Hoos,Robert C. Flanigan,Robert A. Figlin,Pramod K. Srivastava

A multicenter randomized study of adjuvant heat-shock protein peptide-complex 96 (HSPPC-96) vaccine in patients with high-risk of recurrence after nephrectomy for renal cell carcinoma (RCC)-a preliminary report.

2004

Christopher G. Wood
Bernard Escudier
S. Gorelov
K. Krajka
Louis Lacombe
S. D. Fosså
Axel Hoos
Robert C. Flanigan
Robert A. Figlin
Pramod K. Srivastava

2618 Background: HSPPC-96 is an autologous, polyvalent vaccine produced from resected cancer tissue. This trial investigates the use of HSPPC-96 versus observation in patients with RCC at high-risk...

Keywords:

Heat Shock Protein Peptide Complex-96
Randomized controlled trial
HSPPC-96 vaccine
Adjuvant
Oncology
Renal cell carcinoma
Nephrectomy
Internal medicine
Medicine
in patient
Cancer
Polyvalent Vaccine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations